Skip to main content

Table 7 Ongoing clinical trials, phase 4 studies

From: COVID-19 pandemic crisis—a complete outline of SARS-CoV-2

Study title

Conditions

Interventions

Locations

Evaluation of Ganovo (danoprevir) combined with ritonavir in the treatment of SARS-CoV-2 infection

COVID-19

Drug: Ganovo + ritonavir/interferon nebulization

• The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China

The use of tocilizumab in the management of patients who have severe COVID-19 with suspected pulmonary hyper inflammation

COVID-19 pneumonia

Drug: tocilizumab

• Hadassah Medical Orginisation, Jerusalem, Israel

• Barzilai Medical Center, Ashkelon, Israel

• Wolfson Medical Center, Holon, Israel

• Sheba Medical Center, Ramat Gan, Israel

Fluoxetine to reduce intubation and death after COVID19 infection

COVID-19 cytokine storm

Drug: fluoxetine

University of Toledo, Toledo, OH, USA

Hydroxychloroquine and zinc with either azithromycin or doxycycline for treatment of COVID-19 in outpatient setting

COVID-19

Drug: hydroxychloroquine, azithromycin, zinc sulfate, doxycycline

St Francis Hospital, Roslyn, NY, USA

Favipiravir in hospitalized COVID-19 patients

COVID-19

Drug: favipiravir, hydroxychloroquine

Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran

Azithromycin in hospitalized COVID-19 patients

COVID-19

Drug: hydroxychloroquine, azithromycin

Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of

Prophylaxis of exposed COVID-19 individuals with mild symptoms using chloroquine compounds

• SARS-CoV2

• Symptomatic condition

• COVID-19

• Drug: hydroxychloroquine sulfate regular dose, hydroxychloroquine sulfate loading dose, chloroquine, placebo

• Expo COVID Isolation Center/Mayo Hospital Field Hospital, Lahore, Punjab, Pakistan

• Mayo Hospital/King Edward Medical University, Lahore, Punjab, Pakistan

• Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan

BCG vaccine for health care workers as defense against COVID 19

• Coronavirus

• Coronavirus infection

• Coronavirus as the cause of diseases classified elsewhere

• Biological: BCG vaccine

• Biological: placebo vaccine

• Cedars-Sinai Medical Center, Los Angeles, CA, USA

• Harvard T.H. Chan School of Public Health, Boston, MA, USA

• Texas A&M Family Care Clinic, Bryan, TX, USA and 4 more

Hydroxychloroquine in patients with newly diagnosed COVID-19 compared to standard of care

• COVID-19

• Coronavirus Infection

• SARS-CoV-2

• 2019-nCoV

• 2019 novel coronavirus

• Drug: hydroxychloroquine

• Dietary supplement: vitamin C

Portland Providence Medical Center, Portland, OR, USA

Efficacy of dexamethasone treatment for patients with ARDS caused by COVID-19

Acute respiratory distress syndrome caused by COVID-19

• Drug: dexamethasone

• ICU, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain

• Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain

• Department of Anesthesia, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain and 21 more